10
Participants
Start Date
August 31, 2010
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
Ranibizumab
Subtenon injections of Ranibizumab 0.5mg will be given, and repeated twice with 30 day intervals between each dose. Note, after an amendment in February 2011, this dose was increased to 2mg with the same schedule.
University of New Mexico Health Science Center, Albuquerque
Collaborators (1)
Genentech, Inc.
INDUSTRY
University of New Mexico
OTHER